Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Pasireotide LAR 60 mg
DRUG
2 trials
Sponsors
Radboud University Medical Center
, Erasmus Medical Center
Conditions
Acromegaly
Symptomatic Dominant Liver Cyst
Phase 3
Efficacy of Combining Pasireotide With Aspiration Sclerotherapy to Improve Volume Reduction of Hepatic Cysts
Completed
NCT02048319
Radboud University Medical Center
Symptomatic Dominant Liver Cyst
Start: 2013-12-31
End: 2016-04-30
Updated: 2016-05-04
Phase 4
Pasireotide LAR and Pegvisomant Study in Acromegaly
NCT02668172
Erasmus Medical Center
Acromegaly
Start: 2015-08-31
End: 2017-06-30
Updated: 2016-08-03
Related Papers
Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts.
2018-12-12
17 citations
Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trial.
2015-03-07
8 citations